UY25557A1 - Combinaciones terapeúticas para la fragilidad musculoesquelética - Google Patents

Combinaciones terapeúticas para la fragilidad musculoesquelética

Info

Publication number
UY25557A1
UY25557A1 UY25557A UY25557A UY25557A1 UY 25557 A1 UY25557 A1 UY 25557A1 UY 25557 A UY25557 A UY 25557A UY 25557 A UY25557 A UY 25557A UY 25557 A1 UY25557 A1 UY 25557A1
Authority
UY
Uruguay
Prior art keywords
compositions
fragility
pyridin
oxo
phenyl
Prior art date
Application number
UY25557A
Other languages
English (en)
Spanish (es)
Inventor
Hua Z Ke Mei Li Lydia Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY25557A1 publication Critical patent/UY25557A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
UY25557A 1998-06-16 1999-06-11 Combinaciones terapeúticas para la fragilidad musculoesquelética UY25557A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
UY25557A1 true UY25557A1 (es) 2001-01-31

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25557A UY25557A1 (es) 1998-06-16 1999-06-11 Combinaciones terapeúticas para la fragilidad musculoesquelética

Country Status (29)

Country Link
EP (1) EP1085867A1 (hr)
JP (1) JP2002518328A (hr)
KR (1) KR20010052817A (hr)
CN (1) CN1305378A (hr)
AP (1) AP9901581A0 (hr)
AR (1) AR018868A1 (hr)
AU (1) AU3342099A (hr)
BG (1) BG105128A (hr)
BR (1) BR9911357A (hr)
CA (1) CA2335112A1 (hr)
CO (1) CO5070586A1 (hr)
EA (1) EA200001189A1 (hr)
GT (1) GT199900083A (hr)
HR (1) HRP20000857A2 (hr)
HU (1) HUP0102395A2 (hr)
ID (1) ID26726A (hr)
IL (1) IL139587A0 (hr)
IS (1) IS5727A (hr)
MA (1) MA26648A1 (hr)
NO (1) NO20006381L (hr)
OA (1) OA11569A (hr)
PA (1) PA8472101A1 (hr)
PE (1) PE20000633A1 (hr)
PL (1) PL345064A1 (hr)
SK (1) SK18902000A3 (hr)
TN (1) TNSN99118A1 (hr)
UY (1) UY25557A1 (hr)
WO (1) WO1999065488A1 (hr)
ZA (1) ZA993973B (hr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (en) * 1998-08-06 2000-06-07 Pfizer Products Inc. Estrogen agonists/antagonists
JP2004507502A (ja) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク 成長ホルモン分泌促進物質のための徐放性製剤
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
EP1666033B1 (en) * 2001-11-29 2008-12-31 GTX, Inc. Prevention and treatment of androgen-deprivation induced osteoporosis
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
JP2010518090A (ja) 2007-02-09 2010-05-27 トランザイム・ファーマ，インコーポレイテッド 大環状グレリン受容体修飾因子およびその使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
ID26726A (id) 2001-02-01
PL345064A1 (en) 2001-11-19
EP1085867A1 (en) 2001-03-28
TNSN99118A1 (fr) 2005-11-10
IL139587A0 (en) 2002-02-10
NO20006381D0 (no) 2000-12-14
GT199900083A (es) 2000-12-05
AU3342099A (en) 2000-01-05
WO1999065488A1 (en) 1999-12-23
SK18902000A3 (sk) 2001-12-03
CA2335112A1 (en) 1999-12-23
BG105128A (en) 2001-11-30
HUP0102395A2 (hu) 2001-11-28
EA200001189A1 (ru) 2001-06-25
MA26648A1 (fr) 2004-12-20
JP2002518328A (ja) 2002-06-25
AR018868A1 (es) 2001-12-12
KR20010052817A (ko) 2001-06-25
ZA993973B (en) 2000-12-15
CO5070586A1 (es) 2001-08-28
OA11569A (en) 2004-07-01
CN1305378A (zh) 2001-07-25
BR9911357A (pt) 2001-03-13
HRP20000857A2 (en) 2001-10-31
AP9901581A0 (en) 1999-06-30
IS5727A (is) 2000-11-24
PE20000633A1 (es) 2000-07-26
PA8472101A1 (es) 2000-09-29
NO20006381L (no) 2000-12-14

Similar Documents

Publication Publication Date Title
PT1222195E (pt) Novos compostos de tiazolo(4,5-d)pirimidina
EA200400735A1 (ru) 3-β-D-РИБОФУРАНОЗИЛТИАЗОЛО[4,5-d]ПИРИМИДИННУКЛЕОЗИДЫ И ИХ ПРИМЕНЕНИЯ
BG111017A (bg) Нови кристални и аморфна форми на съединението триазоло (4, 5- d)пиримидин
EE04018B1 (et) Tieno[2,3-d]pürimidiindioonid, nende valmistamisemeetod ja neid sisaldavad ravimkoostised
HUP0402270A2 (hu) [1,2,4]Triazolo[1,5-c]pirimidin-5-il-aminok mint adenozin A2a receptor antagonisták és az ezeket tartalmazó gyógyszerkészítmények
UY25557A1 (es) Combinaciones terapeúticas para la fragilidad musculoesquelética
SE0101322D0 (sv) Novel compounds
MXPA03000439A (es) Nueva forma de (r)-n-(5-metil -8-(4-metilpiperazin -1-il) -1,2,3,4-tetrahidro-2-naftil) -4-morfolinobenzamida.
BR9911228A (pt) Combinações terapêuticas compreendendo um modulador seletivo de um receptor de estrogênio e hormÈnio paratireóide
AR018869A1 (es) Composicion farmaceutica, su uso para la preparacion de medicamentos y estuche que la contiene
ECSP993021A (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica
ECSP993020A (es) Terapia de combinacion para la fragilidad musculoesqueletica
SE0100296D0 (sv) New compounds
GB9211277D0 (en) Pharmaceutical compositions
HA et al. A Study on Osteoarthrosis in Korean Young Women Volley Ball Players
TH48282A (th) การรักษาโรคของการให้ยาประกอบร่วมกันของโรคกระดูกพรุน
AR015307A1 (es) Formas cristalinas de monoclorhidrato de pirazinas, composiciones, metodo de tratamiento que las utiliza y metodo de preparacion de dichas formas.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20110408